Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease

Hepato-Gastroenterology

Volumn 53, Issue 71, 2006, Pages 792-796

  Liou, Jyh Ming ^a   Chen, Chi Yi ^b   Wu, Ming Shiang ^a   Hsu, Ming Tse ^b   Fang, Chien Chung ^b   Lin, Yu G ^b   Chang, Ming Chu ^a   Lin, Jaw Town ^a   Wang, Hsiu Po ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Helicobacter pylori; Modified release clarithromycin; Peptic ulcer disease

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; ERADICATION THERAPY; FEMALE; GASTROSCOPY; HELICOBACTER PYLORI; HUMAN; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULCER HEALING; UNSPECIFIED SIDE EFFECT; UREA BREATH TEST;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; PROTON PUMPS;

EID: 33750584350     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Malfertheiner P, Megraund R, O'Morain C, et al: Current concepts in the management of Helicobacter pylori infection-The Maastricht 2000 Consensus Report. Aliment Pharmacol Ther 2002; 16:167-180.
2. Gisbert JP, Gonzalex L, Calvet X, et al: Proton pump inhibitor, clarithromycin and either amoxicillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol her 2000; 14:1319-1328.
3. Calvet X, Garcia N, Lopez T, et al: A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther 2000; 14:603-609.
4. Fischbach LA, Goodman KJ, Feldman M, et al: Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis. Int J Epidemiol 2002; 31:128-139.
5. Laheij RJ, Rossum LG, Jansen JB, et al: Evaluation of treatment regimens to cure Helicobacter pylori infection-a meta-analysis. Aliment Pharmacol Ther 1999; 13:857-864.
6. MacLeod CM, Schotzinger RJ, Vanhove GF, et al: Pharmacokinetics and safety of a once-daily clarithromycin formulation. Adv Ther 1999; 16:1-12.
7. Portier H, Filipecki J, Weber P, et al: Five day clarithromycin modified release versus 10 day penicillin V for group A streptococcal pharyngitis: a multi-centre, open-label, randomized study. J Antimicrob Chemother 2002; 49:337-344.
8. Adam D, Glaser-Caldow E, Wachter J, et al: Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection. Clin Ther 2001; 23:585-595.
9. Chu KM, Kwok KF, Law SY, et al: One-week once-daily triple therapy for Helicobacter pylori - a pilot study. Hepatogastroenterology 2000; 47:1624-1626.
10. Chen TS, Chang FY, Chen PC, et al: Simplified 13C-urea breath test with a new infrared spectrometer for diagnosis of Helicobacter pylori infection. J Gastroenterol Hepatol 2003; 18:1237-1243.
11. Mosci AS, Maletta CA, Castro FJ, et al: Relationship between Sakita endoscopic stage and duration of treatment for duodenal ulcer healing. Braz J Med Biol Res 1989: 22:1219-1223.
12. Laine L, Estrada R, Trujillo M, et al: Once-daily therapy for H. pylori infection: a randomized comparison of four regimens. Am J Gastroenterol 1999; 94:962-966.
13. Wheeld on TU, Hoang TT, Phung DC, et al: Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once-daily treatment. Aliment Pharmacol Ther 2003; 18:93-100.
14. Laine L, Fennerty MB, Osato M, et al: Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance. Results of 3 US multicenter, double-blind trials. Am J Gastroenterol 2000; 95:3393-3398.
15. Miner P Jr, Katz PO, Chen Y, et al: Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol 2003; 98:2616-2620.
16. Tulassay Z, Kryszewski A, Dite P, et al: One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease. Eur J Gastroenterol Hepatol 2001; 13:1457-1465.
17. Nakamura M, Spiller RC, Barrett DA, et al: Gastric juice, gastric tissue and blood antibiotic concentrations following omeprazole, amoxicillin and clarithromycin triple therapy. Helicobacter 2003; 8:294-299.